 |
![??? NewImg[1]/Alt ???](065_files/mdct-highlight-nov-2-2014.jpg) |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
Dear MDCT.net users,
Although lung cancer represents one of the main causes of death, accounting for about 27% of
all cancer deaths worldwide, its impact can be reduced and controlled if detected early. For this
purpose, an effective method for screening is paramount for diagnosing lung cancer in the
asymptomatic stages and, subsequently, for administering appropriate treatment. The sensitivity of
low-dose CT for early lung cancer detection and its superiority to chest radiography have been
established in numerous trials.
Recently, the US Preventive Services Task Force has developed guidelines on screening for
lung cancer, taking into account the accumulated evidence for the effectiveness and safety of
low-dose CT as a primary screening tool. This topic is specifically discussed in a review of these
recent recommendations presented here and is further covered in the selected e-book and related
publications. Additionally, the clinical cases from the MDCT.net archive illustrate some examples
of the use of the MDCT in the differential diagnosis of lung cancer. Finally, a Focus on by Dr.
Anzidei illustrates how to identify arterial anatomy on CT images, also in the thoracic
region.
We welcome suggestions for new topics to be covered in future issues: please contact us
at
editorial@mdct.net
.
From the MDCT.net team
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Low-dose CT for lung cancer screening in an at-risk population: now recommended by the US Preventive Services Task Force
M. Anzidei, V. Matarese
view »
|
|
 |
 |
 |
 |
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
|